Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/7/22 → 12/31/24 |
Funding
- Novartis Pharmaceuticals Corporation: $91,835.40
Efficacy & safety of QGE031 in peanut allergy
- Lehman, Heather (PI)
Project: Research
Project: Research
| Status | Finished |
|---|---|
| Effective start/end date | 01/7/22 → 12/31/24 |